OTCMKTS:FQVTF

Fevertree Drinks Price Target, Predictions & Analyst Ratings

$18.79

-1.21 (-6.05%)

(As of 05/18/2022 02:38 PM ET)

Add

Compare

Today's Range: $18.79
▼
$18.90
50-Day Range: $17.74
▼
$25.22
52-Week Range: $17.74
▼
$38.63

Volume: 300 shs
Average Volume: 1,604 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

Fevertree Drinks (OTCMKTS:FQVTF) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Hold
Based on 13 Analyst Ratings

Analyst Price Target Consensus

$2,223.33
11,732.54% Upside

High PT	$3,200.00
Average PT	$2,223.33
Low PT	$1,600.00

Type	Current 5/18/21 to 5/18/22	1 Month Ago 4/18/21 to 4/18/22	3 Months Ago 2/17/21 to 2/17/22	1 Year Ago 5/18/20 to 5/18/21
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	5 Hold rating(s)	3 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)	3 Sell rating(s)
Consensus Price Target	$2,223.33	$2,223.33	$3,200.00	N/A
Price Target Upside	11,732.54% Upside	9,209.88% Upside	11,128.07% Upside	N/A

Get Fevertree Drinks Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for FQVTF and its competitors with MarketBeat's FREE daily newsletter.

Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Fevertree Drinks (OTCMKTS:FQVTF) vs. Its Competitors

Type	Fevertree Drinks	Consumer Defensive Companies	S&P 500
Consensus Rating Score	2.23	2.46	2.53
Consensus Rating	Hold	Hold	Buy
Price Target Upside	11,732.54% Upside	79.18% Upside	29.36% Upside
News Sentiment Rating	Neutral News	Neutral News	Neutral News
MarketBeat Community Rating	Outperform Votes 31 48.44% Underperform Votes 33 51.56%	Avg. Outperform Votes 114 62.64% Avg. Underperform Votes 68 37.36%	Avg. Outperform Votes 839 69.34% Avg. Underperform Votes 371 30.66%

Fevertree Drinks (OTCMKTS:FQVTF) Analyst Ratings History

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/1/2022	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Price Target		GBX 2,200 ➝ GBX 2,000
4/1/2022	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Emma Letheren Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold	$1,600.00	+6,577.79%
3/18/2022	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Price Target		GBX 1,650 ➝ GBX 1,800
3/17/2022	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mitch Collett Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		GBX 3,500 ➝ GBX 3,350
3/17/2022	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mandeep Sangha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		GBX 3,200 ➝ GBX 3,030
3/17/2022	Liberum Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
3/14/2022	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeff Stent Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold	$1,870.00	+8,912.04%
3/14/2022	Exane BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeff Stent Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	GBX 3,000 ➝ GBX 1,870
1/31/2022	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Sell ➝ Neutral
1/18/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy

12/3/2021	Peel Hunt Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold
10/12/2021	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
7/22/2021	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Sell
1/29/2021	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Sell
9/17/2020	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy

(Data available from 5/18/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Fevertree Drinks (OTCMKTS:FQVTF) Analyst Ratings Frequently Asked Questions

What is Fevertree Drinks's consensus rating and price target?: According to the issued ratings of 13 analysts in the last year, the consensus rating for Fevertree Drinks stock is Hold based on the current 1 sell rating, 8 hold ratings and 4 buy ratings for FQVTF. The average twelve-month price target for Fevertree Drinks is $2,223.33 with a high price target of $3,200.00 and a low price target of $1,600.00. Learn more on FQVTF's analyst rating history.
Do Wall Street analysts like Fevertree Drinks more than its competitors?: Analysts like Fevertree Drinks stock less than the stock of other Consumer Defensive companies. The consensus rating score for Fevertree Drinks is 2.23 while the average consensus rating score for consumer defensive companies is 2.46. Learn more on how FQVTF compares to other companies.
Do MarketBeat users like Fevertree Drinks more than its competitors?: MarketBeat users like Fevertree Drinks stock less than the stock of other Consumer Defensive companies. 48.44% of MarketBeat users gave Fevertree Drinks an outperform vote while consumer defensive companies recieve an average of 62.64% outperform votes by MarketBeat users.

Is Fevertree Drinks being upgraded or downgraded by Wall Street analysts?: Over the previous 90 days, Fevertree Drinks's stock had 2 upgrades and 2 downgrades by analysts.
Does Fevertree Drinks's stock price have much upside?: According to analysts, Fevertree Drinks's stock has a predicted upside of 9,209.88% based on their 12-month price targets.
What analysts cover Fevertree Drinks?: Fevertree Drinks has been rated by Barclays, BNP Paribas, Deutsche Bank Aktiengesellschaft, Exane BNP Paribas, JPMorgan Chase & Co., Liberum Capital, Morgan Stanley, and Royal Bank of Canada in the past 90 days.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources